Cargando…
Bromodomain protein inhibition: a novel therapeutic strategy in rheumatic diseases
The reading of acetylation marks on histones by bromodomain (BRD) proteins is a key event in transcriptional activation. Small molecule inhibitors targeting bromodomain and extra-terminal (BET) proteins compete for binding to acetylated histones. They have strong anti-inflammatory properties and exh...
Autor principal: | Klein, Kerstin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269638/ https://www.ncbi.nlm.nih.gov/pubmed/30564450 http://dx.doi.org/10.1136/rmdopen-2018-000744 |
Ejemplares similares
-
Novel protective role for MAP kinase phosphatase 2 in inflammatory arthritis
por: Schroeder, Juliane, et al.
Publicado: (2019) -
Systemic blockade of proBDNF inhibited the expansion and altered the transcriptomic expression in CD3(+)B220(+) cells in MRL/lpr lupus mice
por: Zha, An-Hui, et al.
Publicado: (2022) -
Technical note: novel delivery methods for an enterotoxigenic Escherichia coli infection model in MUC4-locus sequenced weaner pigs()
por: Sterndale, Samantha O, et al.
Publicado: (2019) -
New animal model of chronic gout reproduces pathological features of the disease in humans
por: Wang, Jiwei, et al.
Publicado: (2023) -
Targeting mitochondrial oxidative stress with MitoQ reduces NET formation and kidney disease in lupus-prone MRL-lpr mice
por: Fortner, Karen A, et al.
Publicado: (2020)